You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

RESERPINE AND HYDROCHLOROTHIAZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Reserpine And Hydrochlorothiazide, and what generic alternatives are available?

Reserpine And Hydrochlorothiazide is a drug marketed by Barr, Sandoz, and West Ward. and is included in four NDAs.

The generic ingredient in RESERPINE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.

Summary for RESERPINE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for RESERPINE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for RESERPINE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
US Department of Veterans Affairs
VA Office of Research and Development

See all RESERPINE AND HYDROCHLOROTHIAZIDE clinical trials

US Patents and Regulatory Information for RESERPINE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 084580-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West Ward RESERPINE AND HYDROCHLOROTHIAZIDE-50 hydrochlorothiazide; reserpine TABLET;ORAL 088189-001 May 10, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Barr RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 084579-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 088200-001 Jan 31, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.